Trials / Completed
CompletedNCT01138878
HIV Testing in Non-traditional Settings Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,350 (actual)
- Sponsor
- Chelsea and Westminster NHS Foundation Trust · Academic / Other
- Sex
- All
- Age
- 16 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Surveillance data suggests that approximately one third of the 82 000 HIV infected adults in the UK remain undiagnosed - that is, they are living with the infection but do not know this. The majority of HIV testing in the UK to date has taken place in sexual health clinics and in antenatal care. Published National guidelines advocate routine HIV testing of 16-65 year olds in more general healthcare settings in parts of the country with relatively high rates of HIV (more than 2 per thousand individuals diagnosed locally). The HINTS Study investigates the utility, feasibility and acceptability, to patients and staff, of offering routine HIV testing in four general medical settings, all set in areas of high HIV prevalence. The settings comprise: Primary Care, Outpatients, an Acute Care Unit and an Emergency Department.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Questionnaire | Administration of written questionnaire to assess attitudes towards the introduction of routine HIV testing programmes to that healthcare setting |
| OTHER | Focus Group Discussion | FGD to explore attitudes within each group towards the introduction of routine HIV screening programmes in each medical setting |
| OTHER | HIV test (serum or salivary) | An HIV test offered to all 16-65 year olds (not known already to be HIV-positive) accessing the healthcare setting during the twelve week pilot period |
| OTHER | Semi-structured telephone interview | Telephone interview administered to patients offered an HIV test during the pilot period |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-07-01
- Completion
- 2011-12-01
- First posted
- 2010-06-08
- Last updated
- 2012-04-12
Locations
4 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01138878. Inclusion in this directory is not an endorsement.